1-7 of 7
Paramita M. Ghosh
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting Galectin-1 Impairs Castration-Resistant Prostate Cancer Progression and Invasion

Free
Tsung-Chieh Shih, Ruiwu Liu, Chun-Te Wu, Xiaocen Li, Wenwu Xiao, Xiaojun Deng, Sophie Kiss, Ting Wang, Xiao-Jia Chen, Randy Carney, Hsing-Jien Kung, Yong Duan, Paramita M. Ghosh, Kit S. Lam
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (17): 4319–4331.
https://doi.org/10.1158/1078-0432.CCR-18-0157
Published: 04 September 2018
View articletitled, Targeting Galectin-1 Impairs Castration-Resistant Prostate Cancer Progression and Invasion
Open the PDF for Targeting Galectin-1 Impairs Castration-Resistant Prostate Cancer Progression and Invasion in another window
Includes: Supplementary data
Journal Articles

Abstract A21: Dual-kinase inhibition of EGFR/ERBB2 as a therapeutic strategy in prostate cancer

Free
Maitreyee K. Jathal, Benjamin A. Mooso, Leandro S. D'Abronzo, Paramita M. Ghosh
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (10_Supplement): A21.
https://doi.org/10.1158/1078-0432.MECHRES-A21
Published: 04 March 2013
View articletitled, Abstract A21: Dual-kinase inhibition of EGFR/ERBB2 as a therapeutic strategy in prostate cancer
Open the PDF for Abstract A21: Dual-kinase inhibition of EGFR/ERBB2 as a therapeutic strategy in prostate cancer in another window
Journal Articles

Abstract A22: Effectiveness of ErbB inhibitors in the treatment of bladder cancer

Free
Benjamin A. Mooso, Paramita M. Ghosh
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (10_Supplement): A22.
https://doi.org/10.1158/1078-0432.MECHRES-A22
Published: 04 March 2013
View articletitled, Abstract A22: Effectiveness of ErbB inhibitors in the treatment of bladder cancer
Open the PDF for Abstract A22: Effectiveness of ErbB inhibitors in the treatment of bladder cancer in another window
Journal Articles

Dual EGFR/HER2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Withdrawal by Suppressing ErbB3

Free
Liqun Chen, Benjamin A. Mooso, Maitreyee K. Jathal, Anisha Madhav, Sherra D. Johnson, Elyse van Spyk, Margarita Mikhailova, Alexandra Zierenberg-Ripoll, Lingru Xue, Ruth L. Vinall, Ralph W. deVere White, Paramita M. Ghosh
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (19): 6218–6228.
https://doi.org/10.1158/1078-0432.CCR-11-1548
Published: 02 October 2011
View articletitled, Dual EGFR/HER2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Withdrawal by Suppressing ErbB3
Open the PDF for Dual EGFR/HER2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Withdrawal by Suppressing ErbB3 in another window
Includes: Supplementary data
Journal Articles

Nuclear versus Cytoplasmic Localization of Filamin A in Prostate Cancer: Immunohistochemical Correlation with Metastases

Free
Roble G. Bedolla, Yu Wang, Alfredo Asuncion, Karim Chamie, Salma Siddiqui, Maria M. Mudryj, Thomas J. Prihoda, Javed Siddiqui, Arul M. Chinnaiyan, Rohit Mehra, Ralph W. de Vere White, Paramita M. Ghosh
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (3): 788–796.
https://doi.org/10.1158/1078-0432.CCR-08-1402
Published: 02 February 2009
View articletitled, Nuclear versus Cytoplasmic Localization of Filamin A in Prostate Cancer: Immunohistochemical Correlation with Metastases
Open the PDF for Nuclear versus Cytoplasmic Localization of Filamin A in Prostate Cancer: Immunohistochemical Correlation with Metastases in another window
Includes: Supplementary data
Journal Articles

Determining Risk of Biochemical Recurrence in Prostate Cancer by Immunohistochemical Detection of PTEN Expression and Akt Activation

Free
Roble Bedolla, Thomas J. Prihoda, Jeffrey I. Kreisberg, Shazli N. Malik, Naveen K. Krishnegowda, Dean A. Troyer, Paramita M. Ghosh
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (13): 3860–3867.
https://doi.org/10.1158/1078-0432.CCR-07-0091
Published: 02 July 2007
View articletitled, Determining Risk of Biochemical Recurrence in Prostate Cancer by Immunohistochemical Detection of PTEN Expression and Akt Activation
Open the PDF for Determining Risk of Biochemical Recurrence in Prostate Cancer by Immunohistochemical Detection of PTEN Expression and Akt Activation in another window
Journal Articles

Immunohistochemical Demonstration of Phospho-Akt in High Gleason Grade Prostate Cancer

Free
Shazli N. Malik, Michael Brattain, Paramita M. Ghosh, Dean A. Troyer, Thomas Prihoda, Roble Bedolla, Jeffrey I. Kreisberg
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (4): 1168–1171.
Published: 01 April 2002
View articletitled, Immunohistochemical Demonstration of Phospho-Akt in High Gleason Grade Prostate Cancer
Open the PDF for Immunohistochemical Demonstration of Phospho-Akt in High Gleason Grade Prostate Cancer in another window